Brief: Interpace Biosciences Q3 Revenue USD 8.756 Million
12/11/2025 21:01
Nov 12 (Reuters) - Interpace Biosciences Q3 net income USD 911 thousand. Q3 operating expenses USD 4.294 million Q3 gross profit USD 5.439 million Q3 operating income USD 1.145 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million